Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Helicobacter. 2023 Aug;28(4):e12972. doi: 10.1111/hel.12972. Epub 2023 Mar 25.
Detection of mutations in one or a couple of genes may not provide enough data or cover all the genomic DNA variance related to antibiotic resistance of Helicobacter pylori to clarithromycin (CLA) and levofloxacin (LVX). We aimed to perform whole genome sequencing to explore novel antibiotic resistance-related genes to increase predictive accuracy for future targeted sequencing tests.
Gastric mucosal biopsies were taken during upper endoscopy in 27 H. pylori-infected patients. According to culture-based antibacterial susceptibility test, H. pylori strains were divided into three groups, with nine strains in each group: CLA single-drug resistance (group C), LVX single-drug resistance (group L), and strains sensitive to all antibacterial drugs (group S). Based on whole genome sequencing with group S being the control, group C and group L group-specific single nucleotide variants and amino acid mutations were screened, and potential candidate genes related to CLA and LVX resistance were identified.
The median age of study subjects was 35 years (IQR: 31-40), and 17 (63.0%) were male. All nine CLA-resistant strains had A2143G mutations in 23S rRNA, while none of nine sensitive strains had the mutation. Six of nine strains in group L and six of nine strains in group S had 87th or 91st mutation in gyrA. After comparing sequencing data of strains among the three groups, we identified five mutated positions belonging to four genes related to CLA resistance, and 31 mutated positions belonging to 20 genes related to LVX resistance. Novel genetic mutations were detected for CLA resistance (including fliJ and clpX) and LVX resistance (including fliJ, cheA, hemE, Val360Ile, and HP0568). Missense mutations in fliJ and cheA gene were mainly involved in chemotaxis and flagellar motility to facilitate bacterial escape of antibiotics, while the functions of other novel gene mutations underpinning antibiotic resistance remain to be investigated.
Whole genome sequencing detected potential novel genetic mutations conferring resistance of H. pylori to CLA and LVX including fliJ and cheA. Further studies to correlate these findings with treatment outcome should be performed.
检测一个或几个基因的突变可能无法提供足够的数据或涵盖与幽门螺杆菌克拉霉素(CLA)和左氧氟沙星(LVX)耐药相关的所有基因组 DNA 变异。我们旨在进行全基因组测序,以探索新的抗生素耐药相关基因,提高未来靶向测序试验的预测准确性。
在上消化道内镜检查中,从 27 例幽门螺杆菌感染患者中采集胃黏膜活检。根据基于培养的抗菌药敏试验,将幽门螺杆菌菌株分为三组,每组 9 株:CLA 单药耐药(C 组)、LVX 单药耐药(L 组)和所有抗菌药物敏感(S 组)。以 S 组为对照,对 C 组和 L 组进行全基因组测序,筛选组特异性单核苷酸变异和氨基酸突变,并鉴定与 CLA 和 LVX 耐药相关的潜在候选基因。
研究对象的中位年龄为 35 岁(IQR:31-40),17 人(63.0%)为男性。所有 9 株 CLA 耐药株 23S rRNA 中均有 A2143G 突变,而 9 株敏感株均无该突变。L 组 9 株中有 6 株和 S 组 9 株中有 6 株 gyrA 第 87 位或第 91 位突变。比较三组菌株的测序数据后,我们鉴定了与 CLA 耐药相关的四个基因的五个突变位置,以及与 LVX 耐药相关的 20 个基因的 31 个突变位置。检测到 CLA 耐药(包括 fliJ 和 clpX)和 LVX 耐药(包括 fliJ、cheA、hemE、Val360Ile 和 HP0568)的新型基因突变。fliJ 和 cheA 基因中的错义突变主要涉及趋化性和鞭毛运动,以促进细菌逃避抗生素,而其他新型基因突变的功能支持抗生素耐药性仍有待研究。
全基因组测序检测到幽门螺杆菌对 CLA 和 LVX 耐药的潜在新型遗传突变,包括 fliJ 和 cheA。应进一步开展相关研究,以确定这些发现与治疗结果的相关性。